A pilot trial of GM-CSF and MDX-H210 in patients with erbB-2-positive advanced malignancies. [electronic resource]
Producer: 19990928Description: 371-9 p. digitalISSN:- 1524-9557
- Adenocarcinoma -- drug therapy
- Adolescent
- Adult
- Aged
- Antibodies, Bispecific -- administration & dosage
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antibody Formation -- drug effects
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cytokines -- drug effects
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Granulocyte-Macrophage Colony-Stimulating Factor -- administration & dosage
- Humans
- Injections, Subcutaneous
- Leukocyte Count -- drug effects
- Male
- Middle Aged
- Pilot Projects
- Receptor, ErbB-2 -- blood
- Severity of Illness Index
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.